PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.65%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-18.11%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-140.60%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-140.60%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-103.99%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-100.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-100.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-16.26%
Share reduction while LBL.AX is at 2.48%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-12.92%
Reduced diluted shares while LBL.AX is at 2.48%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-23.93%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-23.16%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-78.54%
Negative 10Y revenue/share CAGR while LBL.AX stands at 228.01%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-49.63%
Negative 5Y CAGR while LBL.AX stands at 46.12%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
4.52%
3Y revenue/share CAGR under 50% of LBL.AX's 25.81%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
151.16%
10Y OCF/share CAGR above 1.5x LBL.AX's 45.65%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
407.95%
5Y OCF/share CAGR above 1.5x LBL.AX's 30.04%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
31.81%
Positive 3Y OCF/share CAGR while LBL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
98.36%
Net income/share CAGR at 50-75% of LBL.AX's 196.67%. Martin Whitman might question if the firm’s product or cost base lags behind.
-146.54%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
84.00%
Positive short-term CAGR while LBL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1408.92%
3Y equity/share CAGR above 1.5x LBL.AX's 29.77%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.38%
Firm’s AR is declining while LBL.AX shows 32.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.37%
Inventory is declining while LBL.AX stands at 6.76%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.51%
Positive asset growth while LBL.AX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
39.13%
Positive BV/share change while LBL.AX is negative. John Neff sees a clear edge over a competitor losing equity.
-58.69%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
42.47%
SG&A growth well above LBL.AX's 28.87%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.